Logo Thing main logo
Logo Thing main logo

Profile

Dr. Vijay Nema
Name : Dr. Vijay Nema
Designation : Scientist E
Division : Molecular Biology
DOB : 01-06-1977
Email ID : vnema@nariindia.org
Area Of Interest : Microbiology, Molecular Biology, Diagnostics, Metagenomics
Awards and Honours
  • Awarded OAR-Sponsored scholarship to attend the 9th IAS Conference on HIV Science (IAS 2017), on 23-26 July 2017 at the Palais des Congrès in Paris, France.
  • Selected through the competitive application procedure under a call for proposals for participation in a workshop under the Indo-U.S. Joint Working Group on Prevention of HIV/AIDS and Sexually Transmitted Diseases. Held in Delhi from 10th to 11th Dec 2015.
  • First Prize in Paryaywachi competition under Hindi Rajbhasha activity at NARI. 2015.
  • Invited to be a panelist during the one day campaign workshop on “Anti-Microbial Resistance: Situation, Needs and Priorities in India” at Venture Center, Pune on 29th August 2015
  • First Prize in Assay Writing competition under Hindi Rajbhasha activity at NARI. 2014.
  • Invited by the organizers of “2nd International Conference on Clinical Microbiology and Microbial genomics” for being a part of organizing committee and chairing a session. Held at Las Vegas in September 2013 (could not attend).
  • Selected for a three months Training Program in Biomedical Informatics at Vanderbilt University, USA under a training grant from the Fogarty International Centre of NIH. (Worked with Dr. Jens Meiler from19 May to17 Aug 2012).
  • First Prize in Assay Writing competition under Hindi Rajbhasha activity at NARI. 2010
  • Best poster award 47th Annual Conference of Association of Microbiologists of India, 2006.
  • Best paper award, National Symposium on Recent Trends in Molecular Biology. Cancer Hospital and Research Institute, Gwalior, India. 2006.
  • Best Poster award, 45th Annual Conference of Association of Microbiologists of India, 2004.
  • Research Fellowship of DRDO, Ministry of Defence, Govt. of India, 2002.
  • CSIR-National Eligibility Test (Lectureship)
  • Qualified Graduate Aptitude Test in Engineering -2001
Work Experience

Work Experience

Post Held

Employer

Duration

Scientist E

ICMR-NARI

Since 1Oct 2019

 

Scientist D

ICMR-NARI

1 Oct 2015-30 Sept 2019

 

Scientist C

ICMR-NARI

2 Feb 2009- 30 Sept 2015

 

Post
Doctoral Trainee

Vanderbilt University

May 2012- Aug 2012

 

List of Grant Recieved

List of grants received

Sr.No.

Title of Project

Duration

Funding Agency

Role

1

Understanding the type and emergence of drug resistant mutations by sequencing the complete genomes of MDR and XDR M.tuberculosis strains by longitudinal follow-up

2 Years

(2018-2020)

DHR

 

 

 

 

2

Effects of Yoga and Naturopathy interventions in inflammatory status of obese patients

1 Year (2019-20)

AYUSH

(NIN)

 

3

Molecular probing of the Mycobacterium tuberculosis isolates with respect to their resistance pattern and conservation pattern of new drug targets

3 Years (2012-2015)

ICMR

 

 

Conference/Training/Workshop Attended

Conferences/Trainings/Workshops Attended

  • 9th Training Programme on “Science Technology & Emerging Trends in Governance” for Scientists & Technologists (October 21-25, 2019) at Indian Institute of Public Administration, New Delhi.
  • One day symposium on One-day Symposium on “Bench to Bedside” NCE Development at Cipla Ltd., Mumbai On 4th of Oct 2018.
  • Two day workshop on “Application of AMD in public health partners in India” at National Institute of Research in Tuberculosis, Chennai, India held on Aug 18th and 19th, 2017.
  • Training on “Current Regulatory Requirements for Members of Institutional Ethics Committees” at National Centre for Cell Science (NCCS), University of Pune, on February 11 - 12, 2015.
  • Training program on “Schedule Y and clinical trial regulations” organized by ethical research initiatives at the National AIDS Research Institute, Pune on 3rd Feb 2015.
  • Workshop on “Preparedness & Diagnosis of Ebola” Organized by the National Institute of Virology (NIV), Pune 26th November -30th November 2014
  • “Introduction to Forensic Science” conducted by the Nanyang technological university through Coursera online system. Nov 2014
  • Workshop on “Basic Perl for Life Sciences” at NCL innovation park under Biosakshat from 7-9Aug 2014.
  • Bioinformatics workshop on “454 Sequencing, Genomics and Resolving Bioinformatics Challenges” held at New Delhi on 22-23 April, 2013.
  • GCLP and Assay Validation training at Regional Training Event, Le Meridian -Pune, India conducted by PPD and DAIDS from 10-13May 2010.
  • Vanderbilt-NARI-NIE bioinformatics workshop on 20 April 2010 at NARI, Pune.
  • “ICGEB-IUBMB Workshop ‘Human RNA Virus’” International Centre for Genetic Engineering and Biotechnology, New Delhi, India Feb 2010.
  • “Indo-German Workshop on Molecular Epidemiology of Infectious Diseases” University of Hyderabad, India. Nov 2008.
  • Basic Training in Recombinant DNA Technology and PCR” Bangalore Genei, Bangalore, India. 2005.
  • Protein Purification and Immunotechniques.” Bangalore Genei, Bangalore, India. 2005.
  • Recent Advances in Diagnostic Virology” at DRDE Gwalior, India 2005.
  • Recombinant DNA Technology and Molecular Detection Techniques” DRDE Gwalior, India. 2003.

 

Number of Publications : 38
List of Publications

List of Publications

  1. Anamika Gupta, Pallavi Sinha, Sunita Rathod, Siva Kumar S, Uma Devi K R, Shampa Anupurba, Vijay Nema*. Genotype analysis of ofloxacin resistant-MDR-TB isolates in a multi-centered study from India and its phenotyping using Nitrate Reductase Assay. In press of IJMR.
  2. Vijay Nema. The Role and Future Possibilities of Next-Generation Sequencing in Studying Microbial Diversity, Editor(s): Surajit Das, Hirak Ranjan Dash, Microbial Diversity in the Genomic Era, Academic Press, 2019, Pages 611-630, ISBN 9780128148495, https://doi.org/10.1016/B978-0-12-814849-5.00034-4
  3. Nema V. Microbial Forensics: Beyond a Fascination. In: Dash H., Shrivastava P., Mohapatra B., Das S. (eds) DNA Fingerprinting: Advancements and Future Endeavors. Springer, Singapore. 2018, Pages 295-306, ISBN 978-981-13-1582-4, https://link.springer.com/chapter/10.1007/978-981-13-1583-1_17
  4. Nema V., Dhas Y., Banerjee J., Mishra N. Phytochemicals: An Alternate Approach Towards Various Disease Management. In: Rani V., Yadav U. (eds) Functional Food and Human Health. Springer, Singapore. 2018, Pages 623-653, ISBN 978-981-13-1122-2, https://link.springer.com/chapter/10.1007/978-981-13-1123-9_27
  5. HariOm Singh, Dharmesh Samani, Vijay Nema, Manisha V. Ghate, and R. R. Gangakhedkar, “IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity,” Mediators of Inflammation, vol. 2018, Article ID 4398150, 13 pages, 2018. doi:10.1155/2018/4398150 (IF 3.54)
  6. Sudhir Kumar Pal, Sanjit Kumar, Vijay Nema*. In silico Structural and dynamical characterization of Probable arabinosyl transferase B (EmbB) mutations in Mycobacterium tuberculosis. 2017. Journal of proteins and proteomics, Vol 8, JPP78, P133. (Abstract publication)
  7. Jain T, Nema V. Gupta M.K., Kango N., Dash H.R., Shrivastava P. Molecular characterization of selected bacterial flora from forensic case exhibits. Rom J Leg Med. 2017. 25:244-250 (IF 0.32)
  8. Nema V. ​Gut flora and its impact on pathogenesis of various studies. Satyalakshmi K, Pradeep M.K, Salwa H (eds.) Text book on Clinical Naturopathy and Yoga. National Institute of Naturopathy, India. 2017:737. ISBN9788193467206
  9. Gupta A, Pal SK, Pandey D, Fakir NA, Rathod S, Sinha D, SivaKumar S, Sinha P, Periera M, Balgam S, Sekar G, UmaDevi KR, Anupurba S, Nema V*. PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. Ann Clin Microbiol Antimicrob. 2017 Aug 18;16(1):56 (IF 3.92)
  10. Singh H, Marathe SD, Nain S, Samani D, Nema V, Ghate MV, Gangakhedkar RR. Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND. J Biosciences. 2017 Sept; 42(3): 481-490 (IF 1.82)
  11. Banerjee J, Nema V, Dhas Y, Mishra N. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications. Biochimie. 2017 Aug;139:9-19 (IF 3.36)
  12. Vijay Nema* and Hari Om Singh (2017) Host Pharmacogenomics: to be Remembered while Planning a Cure for HIV. BAOJ Hiv 3: 022.
  13. Singh H, Lata S, Nema V, Samani D, Ghate M, Gangakhedkar RR. CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity. APMIS. 2017 Jun;125(6):523-535 (IF 2.225)
  14. Gupta A, Nema V (2017) Imminent Weapons in the Field of Tuberculosis Diagnostics and Management. J intern Med Prim Healthcare 2: 005
  15. Singh HO, Lata S, Angadi M, Bapat S, Pawar J, Nema V, Ghate MV, Sahay S, Gangakhedkar RR. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation. Pharmacogenomics J. 2017 Jan;17(1):53-60 (IF: 3.503)
  16. Vaidya KA, Kadam AV and Nema V*. Anti-Retroviral Drugs for HIV: Old and New. Austin J HIV/AIDS Res. 2016; 3(2): 1026.
  17. Sushama Jadhav and Vijay Nema*. (2016); A review on challenges in the development of multiplex assay for quantitative estimation of viral pathogens Int. J. of Adv. Res. 4 (9). 1102-1110 (IF: 5.336)
  18. Anamika Gupta, Vijay Nema and Shampa Anupurba. Detection of Beijing genotype of MDR M. tuberculosis by targeting Rv2820 gene and their association with drug resistance mutations in katG, rpoB and embB, J Infect Dis Ther 2016, 4:4(Suppl)
  19. Singh H, Marathe SD, Nema V, Ghate MV, Gangakhedkar RR. Genetic variation of MMP-2(-735 C>T) and MMP-9(-1562 C>T) gene in risk of development of HAND and severity of HAND. J Gene Med. 2016 Sep;18(9):250-7  (IF 1.56)